These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 11642025)
1. [Analysis of 516 reports of reactions after the transfusion of labile blood products]. Frère MC; Rapaille A; Bouillenne C; Gérard C; Sondag D; Verhees A Transfus Clin Biol; 2001 Aug; 8(4):333-42. PubMed ID: 11642025 [TBL] [Abstract][Full Text] [Related]
2. Hemovigilance network in France: organization and analysis of immediate transfusion incident reports from 1994 to 1998. Andreu G; Morel P; Forestier F; Debeir J; Rebibo D; Janvier G; Hervé P Transfusion; 2002 Oct; 42(10):1356-64. PubMed ID: 12423521 [TBL] [Abstract][Full Text] [Related]
3. Reactions to platelet transfusion: the effect of the storage time of the concentrate. Muylle L; Wouters E; De Bock R; Peetermans ME Transfus Med; 1992 Dec; 2(4):289-93. PubMed ID: 1339583 [TBL] [Abstract][Full Text] [Related]
4. [Analysis of transfusion incident reports filed at 15 blood transfusion centers and health facilities during 17 months. Groupe Receveurs de laSFTS]. Waller C; Vicariot M; Gunzberger H Transfus Clin Biol; 1997 Dec; 4(6):541-8. PubMed ID: 9527419 [TBL] [Abstract][Full Text] [Related]
5. Reduction of febrile but not allergic reactions to RBCs and platelets after conversion to universal prestorage leukoreduction. Paglino JC; Pomper GJ; Fisch GS; Champion MH; Snyder EL Transfusion; 2004 Jan; 44(1):16-24. PubMed ID: 14692962 [TBL] [Abstract][Full Text] [Related]
6. Effect of storage of platelet concentrates in PAS-B, PAS-C, or plasma on transfusion reactions. van Hout FMA; Middelburg RA; van der Meer PF; Pors A; Wiersum-Osselton JC; Schipperus MR; Kerkhoffs JL; van der Bom JG Transfusion; 2019 Oct; 59(10):3140-3145. PubMed ID: 31503334 [TBL] [Abstract][Full Text] [Related]
7. Universal leukodepletion of blood components results in a significant reduction of febrile non-hemolytic but not allergic transfusion reactions. Pruss A; Kalus U; Radtke H; Koscielny J; Baumann-Baretti B; Balzer D; Dörner T; Salama A; Kiesewetter H Transfus Apher Sci; 2004 Feb; 30(1):41-6. PubMed ID: 14746820 [TBL] [Abstract][Full Text] [Related]
8. Haemovigilance in a general university hospital: need for a more comprehensive classification and a codification of transfusion-related events. Siegenthaler MA; Schneider P; Vu DH; Tissot JD Vox Sang; 2005 Jan; 88(1):22-30. PubMed ID: 15663719 [TBL] [Abstract][Full Text] [Related]
9. The effect of prestorage WBC reduction on the rates of febrile nonhemolytic transfusion reactions to platelet concentrates and RBC. Yazer MH; Podlosky L; Clarke G; Nahirniak SM Transfusion; 2004 Jan; 44(1):10-5. PubMed ID: 14692961 [TBL] [Abstract][Full Text] [Related]
10. [Introduction of platelet additive solution in platelet concentrates: towards a decrease of blood transfusion reactions]. Rebibo D; Simonet M; Hauser L Transfus Clin Biol; 2008 Nov; 15(5):289-93. PubMed ID: 18930424 [TBL] [Abstract][Full Text] [Related]
11. Platelet transfusions in children: results of a randomized, prospective, crossover trial of plasma removal and a prospective audit of WBC reduction. Couban S; Carruthers J; Andreou P; Klama LN; Barr R; Kelton JG; Heddle NM Transfusion; 2002 Jun; 42(6):753-8. PubMed ID: 12147029 [TBL] [Abstract][Full Text] [Related]
12. Febrile and allergic transfusion reactions after the transfusion of white cell-poor platelet preparations. Klüter H; Bubel S; Kirchner H; Wilhelm D Transfusion; 1999; 39(11-12):1179-84. PubMed ID: 10604243 [TBL] [Abstract][Full Text] [Related]
13. Immediate transfusion reactions. Climent-Peris C; Vélez-Rosario R P R Health Sci J; 2001 Sep; 20(3):229-35. PubMed ID: 11776724 [TBL] [Abstract][Full Text] [Related]
14. [Hypotension and adverse transfusion reactions: from the associated clinical signs to the hypotensive transfusion reaction]. Py JY; Leo-Kodeli S; Fauveau L; Duedari N; Roubinet F Transfus Clin Biol; 2009 Mar; 16(1):12-20. PubMed ID: 19328031 [TBL] [Abstract][Full Text] [Related]
15. A comparison of adverse reaction rates for PAS C versus plasma platelet units. Cohn CS; Stubbs J; Schwartz J; Francis R; Goss C; Cushing M; Shaz B; Mair D; Brantigan B; Heaton WA Transfusion; 2014 Aug; 54(8):1927-34. PubMed ID: 24735171 [TBL] [Abstract][Full Text] [Related]
16. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components. Dzieczkowski JS; Barrett BB; Nester D; Campbell M; Cook J; Sugrue M; Andersen JW; Anderson KC Transfusion; 1995 Jan; 35(1):20-5. PubMed ID: 7998063 [TBL] [Abstract][Full Text] [Related]
17. Analysis of complications after blood components' transfusions. Timler D; Klepaczka J; Kasielska-Trojan A; Bogusiak K Pol Przegl Chir; 2015 Apr; 87(4):166-73. PubMed ID: 26146115 [TBL] [Abstract][Full Text] [Related]
18. Effects of prestorage vs poststorage leukoreduction on the rate of febrile nonhemolytic transfusion reactions to platelets. Wang RR; Triulzi DJ; Qu L Am J Clin Pathol; 2012 Aug; 138(2):255-9. PubMed ID: 22904138 [TBL] [Abstract][Full Text] [Related]
19. Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs. King KE; Shirey RS; Thoman SK; Bensen-Kennedy D; Tanz WS; Ness PM Transfusion; 2004 Jan; 44(1):25-9. PubMed ID: 14692963 [TBL] [Abstract][Full Text] [Related]
20. [The effect of leukocyte-reduction on the transfusion reactions to red blood cells concentrates]. Mukagatare I; Monfort M; de Marchin J; Gerard C Transfus Clin Biol; 2010 Feb; 17(1):14-9. PubMed ID: 20106700 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]